摩根士丹利研究报告指出，京东健康(06618.HK)公布截至去年12月底止全年业绩，其中去年第四季收入年增27%，比市场预期高4%。调整后营业利益年增246%符预期。调整后净利润增30%，优于其他收入，惟料今年净利润或持平；予集团目标价70元，评级“与大市同步”。公司管理层认为，相较于各类别的竞争对手，其护城河正在拓宽，尤其是对于具有严格履约标准的药品；并否认有意对线下设施进行大规模并购，这应能...
Source Link摩根士丹利研究报告指出，京东健康(06618.HK)公布截至去年12月底止全年业绩，其中去年第四季收入年增27%，比市场预期高4%。调整后营业利益年增246%符预期。调整后净利润增30%，优于其他收入，惟料今年净利润或持平；予集团目标价70元，评级“与大市同步”。公司管理层认为，相较于各类别的竞争对手，其护城河正在拓宽，尤其是对于具有严格履约标准的药品；并否认有意对线下设施进行大规模并购，这应能...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.